Optimizing Positive "Hits" for Potency and Safety
Contacts
For more information on the "Optimizing Positive 'Hits' for Potency and Safety" meeting, please contact:
John A. Bogdan, Ph.D.
Therapeutics Development Program Officer
Drug Development Section
Office of Biodefense Research Affairs
DMID/NIAID/NIH
jbogdan@niaid.nih.gov
Katherine Taylor, Ph.D.
Chief
Drug Development Section
Office of Biodefense Research Affairs
DMID/NIAID/NIH
kataylor@niaid.nih.gov